Homocysteine, vitamins and gene mutations in peripheral arterial disease

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 6, 2001, Pages 469-475

  Stricker, H ^a,c   Soldati, G ^b   Balmelli, T ^b   Mombelli, G ^a  

^a Ospedale Regionale Locarno   (Switzerland)

^b Laboratorio Bioanalitico   (Switzerland)

^c Ospedale Regionale di Locarno   (Switzerland)

Author keywords

Genetics; Homocysteine; Peripheral vascular disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN;

ADULT; AGED; ANGIOPLASTY; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; STATISTICAL ANALYSIS; VITAMIN BLOOD LEVEL;

ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PERIPHERAL VASCULAR DISEASES; VITAMIN B 12;

EID: 0034862752     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200109000-00007     Document Type: Article

References (25)

1. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
2. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
3. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study
4. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
5. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease
6. Homocysteine and vascular disease
7. Abnormal homocysteine metabolism in rheumatoid arthritis
8. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study
9. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
10. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Hyperhomocysteinemia, atherosclerosis and thrombosis
13. Plasma homocysteine as a risk factor for vascular disease
14. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies
15. Blood levels of homocysteine and increased risks of cardiovascular disease
16. An alternative view of homocysteine
17. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
18. Homocysteine and risk of cardiovascular disease among postmenopausal women
19. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
20. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia
21. Homocysteine, vitamins, and cardiovascular disease
22. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
23. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease
24. Homocysteine and risk of premature coronary heart disease
25. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene